시스틴뇨증 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 유형별, 약제별, 투여 경로별, 유통 채널별, 지역별 및 경쟁별 세분화(2020-2030년)
Cystinuria treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Drugs, By Route of Administration, By Distribution Channel, By Region and Competition, 2020-2030F
상품코드:1886386
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 시스틴뇨증 치료 시장은 2024년에 1억 6,000만 달러로 평가되며, 2030년까지 CAGR 4.70%로 성장하며, 2억 1,077만 달러에 달할 것으로 예측됩니다. 세계 시스틴뇨증 치료제 시장은 희귀 유전성 질환인 시스틴뇨증의 증상 중 하나인 요로내 시스틴 결석의 재발을 예방 및 관리하기 위해 고안된 의약품 및 의료적 개입을 포괄합니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
1억 6,000만 달러
시장 규모 : 2030년
2억 1,077만 달러
CAGR : 2025-2030년
4.70%
가장 빠르게 성장하는 부문
티오프로닌
최대 시장
북미
주요 시장 성장 촉진요인
새로운 치료제와 치료법의 발전으로 보다 효과적이고 내약성이 좋은 치료 옵션이 도입되면서 세계 시스틴뇨증 치료제 시장이 크게 성장하고 있습니다. 이 희귀 유전성 질환에 대한 기존 치료법은 종종 심각한 부작용을 동반하고, 환자의 복약 순응도가 떨어지고 결석이 재발하는 원인이 되기도 했습니다.
주요 시장 과제
시스틴뇨증의 고유한 희소성은 치료 시장 성장에 큰 도전이 되고 있습니다. 환자 수가 극히 적기 때문에 새로운 치료법에 대한 대규모 연구개발의 상업적 타당성을 직접적으로 제한하고 있습니다.
주요 시장 동향
눈에 띄는 동향으로는 맞춤형 의료 접근에 대한 강조를 꼽을 수 있습니다. 이는 특정 유전자 돌연변이 및 질병 특성에 따라 개별 환자 프로파일에 맞게 치료 계획을 조정하고, 부작용을 최소화하면서 효능을 높이는 것을 의미합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 시스틴뇨증 치료 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
유형별(시스틴뇨증 유형 1, 시스틴뇨증 유형 2, 시스틴뇨증 유형 3)
약제별(티오프로닌, 페니실라민, 캡토프릴, 기타)
투여 경로별(경구, 주사제)
유통 채널별(병원 약국, 소매 약국, 온라인 약국)
지역별
기업별(2024)
시장 맵
제6장 북미의 시스틴뇨증 치료 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 시스틴뇨증 치료 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 시스틴뇨증 치료 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 시스틴뇨증 치료 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 시스틴뇨증 치료 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 시스틴뇨증 치료 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Travere Therapeutics, Inc
Dr. Reddy's Laboratories Ltd
Advicenne SACA
Teva Pharmaceutical Industries Ltd
ANI Pharmaceuticals, Inc
Viatris Inc
Advanz Pharma Corp
Camber Pharmaceuticals, Inc
Bausch Health Companies Inc
Synact Pharma AB
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Cystinuria treatment Market, valued at USD 160.00 Million in 2024, is projected to experience a CAGR of 4.70% to reach USD 210.77 Million by 2030. The Global Cystinuria treatment market encompasses pharmaceutical and medical interventions designed to prevent and manage the recurrence of cystine calculi in the urinary tract, a manifestation of the rare genetic disorder, cystinuria.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 160.00 Million
Market Size 2030
USD 210.77 Million
CAGR 2025-2030
4.70%
Fastest Growing Segment
Tiopronin
Largest Market
North America
Key Market Drivers
Advancements in Novel Therapeutic Agents and Treatment Modalities significantly propel the Global Cystinuria treatment market by introducing more effective and better tolerated options. Traditional treatments for this rare genetic disorder often presented considerable side effects, contributing to suboptimal patient adherence and persistent stone recurrence. The development of new compounds, drug classes, and innovative delivery methods promises improved outcomes and enhances patient quality of life. Progress in understanding disease pathophysiology facilitates targeted interventions.
Key Market Challenges
The inherent rarity of cystinuria presents a significant challenge to the growth of its treatment market. The extremely small patient population directly limits the commercial viability for extensive research and development into novel therapeutic approaches. Pharmaceutical companies encounter considerable financial risks when investing in treatments for conditions with such limited market potential, as the prospects of recouping substantial R&D costs are diminished. This specialized nature of therapies for rare disorders, coupled with the small patient pool, inevitably contributes to higher per-patient treatment expenses. Such elevated costs can severely restrict global accessibility and adoption, particularly within healthcare systems operating under constrained budgets, thereby hindering broader market penetration.
Key Market Trends
A prominent trend is the Emphasis on Personalized Medicine Approaches. This involves tailoring treatment regimens to individual patient profiles, often based on specific genetic mutations or disease characteristics, to enhance efficacy and minimize adverse effects. This approach marks a departure from conventional generalized treatments, promising more precise interventions for a rare genetic disorder like cystinuria.
Key Market Players
Travere Therapeutics, Inc
Dr. Reddy's Laboratories Ltd
Advicenne SACA
Teva Pharmaceutical Industries Ltd
ANI Pharmaceuticals, Inc
Viatris Inc
Advanz Pharma Corp
Camber Pharmaceuticals, Inc
Bausch Health Companies Inc
Synact Pharma AB
Report Scope:
In this report, the Global Cystinuria treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cystinuria treatment Market, By Type:
Cystinuria Type 1
Cystinuria Type 2
Cystinuria Type 3
Cystinuria treatment Market, By Drugs:
Tiopronin
Penicillamine
Captopril
Others
Cystinuria treatment Market, By Route of Administration:
Oral
Injectables
Cystinuria treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Cystinuria treatment Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Cystinuria treatment Market.
Available Customizations:
Global Cystinuria treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cystinuria treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Cystinuria Type 1, Cystinuria Type 2, Cystinuria Type 3)
5.2.2. By Drugs (Tiopronin, Penicillamine, Captopril, Others)
5.2.3. By Route of Administration (Oral, Injectables)
5.2.4. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Cystinuria treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Drugs
6.2.3. By Route of Administration
6.2.4. By Distribution Channel
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Cystinuria treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Drugs
6.3.1.2.3. By Route of Administration
6.3.1.2.4. By Distribution Channel
6.3.2. Canada Cystinuria treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Drugs
6.3.2.2.3. By Route of Administration
6.3.2.2.4. By Distribution Channel
6.3.3. Mexico Cystinuria treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Drugs
6.3.3.2.3. By Route of Administration
6.3.3.2.4. By Distribution Channel
7. Europe Cystinuria treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Drugs
7.2.3. By Route of Administration
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Cystinuria treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Drugs
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By Distribution Channel
7.3.2. France Cystinuria treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Drugs
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By Distribution Channel
7.3.3. United Kingdom Cystinuria treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Drugs
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By Distribution Channel
7.3.4. Italy Cystinuria treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Drugs
7.3.4.2.3. By Route of Administration
7.3.4.2.4. By Distribution Channel
7.3.5. Spain Cystinuria treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Drugs
7.3.5.2.3. By Route of Administration
7.3.5.2.4. By Distribution Channel
8. Asia Pacific Cystinuria treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Drugs
8.2.3. By Route of Administration
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Cystinuria treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Drugs
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By Distribution Channel
8.3.2. India Cystinuria treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Drugs
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By Distribution Channel
8.3.3. Japan Cystinuria treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Drugs
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By Distribution Channel
8.3.4. South Korea Cystinuria treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Drugs
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By Distribution Channel
8.3.5. Australia Cystinuria treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Drugs
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By Distribution Channel
9. Middle East & Africa Cystinuria treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Drugs
9.2.3. By Route of Administration
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Cystinuria treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Drugs
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By Distribution Channel
9.3.2. UAE Cystinuria treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Drugs
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By Distribution Channel
9.3.3. South Africa Cystinuria treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Drugs
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By Distribution Channel
10. South America Cystinuria treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Drugs
10.2.3. By Route of Administration
10.2.4. By Distribution Channel
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cystinuria treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Drugs
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By Distribution Channel
10.3.2. Colombia Cystinuria treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Drugs
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By Distribution Channel
10.3.3. Argentina Cystinuria treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Drugs
10.3.3.2.3. By Route of Administration
10.3.3.2.4. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Cystinuria treatment Market: SWOT Analysis
